AHGNasdaqServices-Business Services, NECFiscal year ends March 31
Akso Health Group
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 23, 2026
$1.33−0.02 (-1.48%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 133.0
- Dividend yield
- –
Share price
−$0.31 (−18.90%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Akso Health Group saw revenue fall 6.4% to $13.83M over fiscal 2026. Free cash flow was -$12.79M, down 1350.9% from a year earlier.
Revenue
$13.83M
-6.4% vs. a year earlier
Operating income
-$20.70M
FY2026
Free cash flow
-$12.79M
-1350.9% vs. a year earlier
EPS, diluted
$0.01
-93.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- 133.0
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $13.83M
- Net income
- -$18.67M
- EPS, diluted
- $0.01
- Free cash flow
- -$12.79M
Twelve years at a glance
Fiscal years 2015 to 2026, USD
Revenue
$13.83M-6.4% YoY
Gross profit
-$11.32K
Operating income
-$20.70M
Net income
-$18.67M
EPS, diluted
$0.01-93.8% YoY
Free cash flow
-$12.79M-1350.9% YoY
Reported period